Clinical Pediatrics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeshita, S.
Right arrow Articles by Tokutomi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeshita, S.
Right arrow Articles by Tokutomi, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Pediatrics, Vol. 44, No. 5, 423-426 (2005)
DOI: 10.1177/000992280504400507

Standard-dose and Short-term Corticosteroid Therapy in Immunoglobulin-resistant Kawasaki Disease

Seiichiro Takeshita, MD, PhD

University of Shizuoka, Junior College, Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Youichi Kawamura, MD

Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Keigo Nakatani, MD, PhD

Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Hiroshi Tsujimoto, MD, PhD

Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Tomoharu Tokutomi, MD

Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Six patients with Kawasaki disease (KD) were treated with prednisolone (1 to 2 mg/kg/day) for 3 days (from days 10 to 12 after the onset of the illness) after apparently unsuccessful treatment with intravenous immunoglobulin (IVIG, 2 g/kg/dose and additional 1 g/kg/dose). Five patients responded immediately to the first course of prednisolone infusion. One patient failed to respond to the first course of prednisolone therapy, but he did respond to the second 3-day course of therapy. None of the patients demonstrated a further progression of coronary artery dilatation or any adverse effects. Standard-dose and short-term corticosteroid therapy therefore appears to be a safe and effective treatment for patients with IVIG-resistant KD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
M. J. O'Connor and F. T. Saulsbury
Incomplete and Atypical Kawasaki Disease in a Young Infant: Severe, Recalcitrant Disease Responsive to Infliximab
Clinical Pediatrics, May 1, 2007; 46(4): 345 - 348.
[Abstract] [PDF]